joint strategic needs assessment foundation profile - JSNA

Interative Hull Atlas: www.hullpublichealth.org/Pages/hull_atlas.htm More information: www.jsnaonline.org and www.hullpublichealth.org
9.3.2 Cervical Cancer
It is estimated that the human papillomavirus (HPV) is responsible for approximately
95% of all cervical cancers. The HPV vaccination programme started in September
2008 with all 12- to 13-year-old and 17- to 18-year-old girls being offered the vaccine. A
catch-up programme was also announced at this time with 13- to 18-year-old girls being
offered the vaccine over the following two academic years. An accelerated catch-up
programme was announced in December 2008 so that all girls born on or after 1
September 1990 could be protected before the end of the academic year 2009/10 (NHS
Cancer Screening Programme 2009). Further information about the vaccine is available
at www.immunisation.nhs.uk/Vaccines/HPV/. However, it will be many years before the
vaccination programme has an effect upon cervical cancer incidence so there are no
changes planned to the Screening Programme yet. Vaccinated women are advised to
continue accepting their invitations for cervical cancer screening as the vaccination will
not prevent all types of cervical cancer.
All women between the ages of 25 and 64 are eligible for a free cervical cancer
screening test every three to five years. In the light of evidence published in 2003, the
NHS Cervical Screening Programme now offers screening at different intervals
depending on age. This means that women are provided with a more targeted and
effective screening programme. Women are first invited to attend screening once they
reach 25 years of age, and have screening offered every three years until they are 49
years. Screening between the ages of 50 and 64 years is offered every five years.
Screening is offered to women aged 65+ years if they have not been screened since
they were aged 50 years or if they have had recent abnormal tests.
9.3.2.1 Percentage of Women Screened
The estimated percentage (95% CI) of women aged 25 to 64 years attending cervical
cancer screening within the last five years as at 31 st March 2010 (Information Centre for
Health and Social Care 2009) is given in Table 179 for Hull and comparator areas (see
section 3.3.3 on page 44). The rates in Hull (79.2%) were slightly higher than England
(78.9%) and the comparator areas average (78.1%). Similar to most other areas, in
Hull, the target of 80% has not quite been achieved.
Joint Strategic Needs Assessment Foundation Profile – Hull Health Profile: Release 3. March 2011. 421